RachelAnneDavisMD

Instructor, Psychiatry, University of Colorado School of Medicine

Dr. Davis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2012

PubMed

21 citations
Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device Approval.
Lora Kahn, Brianne Sutton, Helena Winston, Aviva Abosch, John A. Thompson
Frontiers in Psychiatry. 2021-03-24
32 citations
Approaches to neuromodulation for schizophrenia
Judith Gault, Rachel A. Davis, Nicola G. Cascella, Elyn R. Saks, Iluminada Corripio-Collado
Journal of Neurology, Neurosurgery, and Psychiatry. 2018-07-01
13 citations
Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity Act.
Rachel A. Davis, James Giordano, D. Brian Hufford, Sameer A. Sheth, Peter C. Warnke
Frontiers in Psychiatry. 2021-08-12

CU Anschutz Medical Campus and the Colorado Behavioral Health Administration Announce Initiative To Increase Diversity in the Behavioral Health WorkforceMay 17th, 2023
Patients with Schizophrenia Have Favorable Surgical Risk, Opening the Door for Ethical Consideration of Neurosurgical Interventions like Deep Brain StimulationApril 3rd, 2023
Study Reveals Lower Surgical Risks for Schizophrenia and Schizoaffective Disorder Patients Considering Deep Brain StimulationApril 3rd, 2023
Join now to see all